
Block deal: The promoters of Sagility Ltd, a company providing technology-based services in the healthcare sector, are planning to sell their 16.4% stake through a block deal. According to sources, the base book of the deal is 10%, while apart from this, a green shoe option of 6.4% has also been kept.
Floor price fixed at 8% discount
Sources said that the floor price for this stake sale has been fixed at ₹ 46.4 per share, which is about 8% cheaper than the current market price (CMP).
Quarterly results were excellent
Sagility’s net profit more than doubled to ₹251 crore in the September quarter, from ₹117 crore last year. The company’s revenue increased by 25.2% to ₹1,658 crore. EBITDA grew 37.7% to ₹415 crore. Operating margin also increased from 22.7% to 25%.
The company had 44,185 employees at the end of the September quarter. It operates through 34 delivery centers in 5 countries.
Board declared interim dividend
Sagility’s board of directors has declared an interim dividend of ₹0.05 per share (face value ₹10). This dividend for FY26 will be decided on the basis of record date of November 12, 2025. This dividend will be paid by 28 November 2025.
CEO said- stable growth even in the changing market
Ramesh Gopalan, Managing Director and Group CEO, Sagility, said that the performance of the first half of FY26 shows that Sagility has been able to maintain consistent growth even in a changing market. “As our clients face pressure on profitability, we are helping them reduce their operating costs through our domain expertise and transformational capabilities,” he said.
Status of Sagility shares
Shares of Sagility closed 2.28% lower at ₹50.47 on the BSE on Thursday. The stock is up 9.08% in 1 month. At the same time, it has given a return of 12.28% in 6 months. Shares have gained 76.41% in the last one year. The market cap of the company is Rs 23.73 thousand crore.
Disclaimer: The information provided here is being given for information only. It is important to mention here that investing in the market is subject to market risks. As an investor, always consult an expert before investing money. Moneycontrol never advises anyone to invest money here.